Feature Type | Standardized | Nominal ANOVA | ||||
---|---|---|---|---|---|---|
mRNA | IPR-456 | CTRPv2 | pan-cancer | AAC | -0.017 | 0.7 |
mRNA | Erlotinib | FIMM | pan-cancer | AAC | 0.072 | 0.7 |
mRNA | PD-0332991 | GDSC1000 | pan-cancer | AAC | 0.015 | 0.7 |
mRNA | YL54 | CTRPv2 | pan-cancer | AAC | 0.017 | 0.7 |
mRNA | lomeguatrib | CTRPv2 | pan-cancer | AAC | 0.016 | 0.7 |
mRNA | Docetaxel | GDSC1000 | pan-cancer | AAC | 0.014 | 0.7 |
mRNA | UNC0321 | CTRPv2 | pan-cancer | AAC | -0.016 | 0.7 |
mRNA | PHA-793887 | GDSC1000 | pan-cancer | AAC | -0.012 | 0.7 |
mRNA | AZD0530 | FIMM | pan-cancer | AAC | 0.068 | 0.7 |
mRNA | SB-225002 | CTRPv2 | pan-cancer | AAC | 0.013 | 0.7 |